Sign in

CIK 0001213037

  • Non-accelerated filer
  • Smaller reporting company

Cardiff Oncology, Inc.

Sign in to watch
Ticker
CRDF
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272004382
Phone
+1 858-952-7570
Business address
11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
Former names
Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Option exercise Director acquired 9,287 shares (option exercise)
  7. 4 Option exercise Director acquired 8,484 shares (option exercise)
  8. 4 Option exercise Director acquired 6,498 shares (option exercise)
  9. 4 Option exercise Director acquired 8,806 shares (option exercise)
  10. 4 Shares withheld for taxes Chief Scientific Officer gave up 12,928 shares (to pay taxes)
  11. 4 Option exercise Director acquired 12,667 shares (option exercise)
  12. 4 Option exercise Director acquired 5,943 shares (option exercise)
  13. 4 Open-market sale Director sold 8,334 shares at $0.69 ($5,750)
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award CEO acquired 745,392 shares (grant or award)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4/A Derivatives Options or other derivatives
  19. 4/A Derivatives Options or other derivatives
  20. 4/A Derivatives Options or other derivatives

Page 10 of 15 · 300 filings